About GLAUKOS CORPORATION
Glaukos is a company focused on developing and leading the global ophthalmic market with novel therapies that advance the existing standard of care and enrich the lives of patients worldwide. The company specializes in cornea cross-linking, glaucoma treatments, and retinal drug delivery platforms.
Cornea cross-linking intervention to slow or halt progressive keratoconusMarket-leading portfolio of innovative glaucoma therapiesDeveloping sustained-release drug delivery platforms for retinal diseases
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| PROSTHETICS. NSC SURGICAL IMPLANT LEFT EYE IDOSE ISENT | Department of Veterans Affairs | $21K | |
| LEFT EYE IDOSE ISENT | Department of Veterans Affairs | $21K | |
| RIGHT EYE IDOSE ISENT | Department of Veterans Affairs | $21K | |
| NSC SURGICAL IMPLANT LEFT EYE IDOSE ISENT | Department of Veterans Affairs | $21K | |
| PROSTHETICS. SURGICAL IMPLANT RIGHT EYE IDOSE ISENT | Department of Veterans Affairs | $21K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GLAUKOS CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.